Results 31 to 40 of about 6,823 (189)
Prevalence, predictors and outcome of pulmonary mucormycosis in COVID-19 associated rhino orbital mucormycosis in a tertiary care centre in south India [PDF]
Current Medical Mycology, 2023 Background and Purpose: India witnessed an explosive rise in mucormycosis following COVID-19 infection. While rhino orbital mucormycosis was the most common presentation, pulmonary mucormycosis was closely followed.
Karthigeyan Thanjavur Sethuraman +3 more
doaj +1 more source
Asian Journal of Internal MedicineAlthough fungal infections are common in clinical practice, usually they are superficial and invasive infections are very rare among immunocompetent people.
P. Dikshaladevi +3 more
doaj +2 more sources
Pulmonary Mucormycosis: An Interesting Case of Rhizopus Mucormycosis [PDF]
Cureus, 2021 We report a case of a 57-year-old Vietnamese gentleman who presented with chest pain and shortness of breath for four weeks. The patient had a history of diabetes mellitus and kidney transplant in the past year and was currently on immunosuppressive agents.
Ukoha, Chijioke D, Nguyen, Nicholas
openaire +2 more sources
Successful treatment of pulmonary mucormycosis caused by Rhizopus microsporus with posaconazole
European Journal of Medical Research, 2021 Background Mucormycosis is a rare fungal infection occurring chiefly in the lung or the rhino-orbital-cerebral compartment, particularly in patients with immunodeficiency or diabetes mellitus. Among Mucorales fungi, Rhizopus spp.
F. Yuan +5 more
doaj +1 more source
Isolated pulmonary mucormycosis [PDF]
BMJ Case Reports, 2017 An obese woman aged 70 years with a history of chronic persistent asthma and diabetes mellitus presented with acute exacerbation and respiratory failure. A chest X-ray and CT scan revealed patchy infiltrates on the right lung along with right hilar and upper lobe masses suggestive of malignancy (figure 1).
Raj Kumar, Mani +3 more
openaire +2 more sources
Pulmonary Mucormycosis with Endobronchial Involvement Complicated by Pleural Effusion. [PDF]
J Clin Pract ResBackground: Pulmonary mucormycosis is an infection caused by a fungus with a severe and often fatal course, with a mortality rate exceeding 50%. It can spread through blood or lymphatic fluids or by inhalation of sporangiospores.
Rabahoğlu B +4 more
europepmc +2 more sources
BMC Pulmonary Medicine, 2021 Background Pulmonary mucormycosis caused by Mucorales is a highly lethal invasive fungal infection usually found in immunocompromised patients. Isolated pulmonary mucormycosis in immunocompetent patients is very rare. Here, we present a case of a 32-year-
Jianhan He +4 more
doaj +1 more source
Archives of Internal Medicine, 1999 Pulmonary mucormycosis is relatively uncommon but an important opportunistic fungal infection in immunocompromised persons. The literature on the subject is sparse. We describe a recent case and review the literature to delineate the clinical characteristics of this infection.
F Y, Lee, S B, Mossad, K A, Adal
openaire +2 more sources
A Rare Case of Fatal Endobronchial Mucormycosis Masquerading as Endobronchial Tuberculosis
Medicina, 2020 Pulmonary mucormycosis is a relatively rare but often fatal opportunistic fungal infection that occurs mostly in immunocompromised patients. Endobronchial mucormycosis, a distinct clinical form of pulmonary mucormycosis, is very rare, and only a few ...
Minjeong Kim +5 more
doaj +1 more source
Pulmonary Mucormycosis With Dissemination: A Case of Unrelenting Fever and Chest Pain
Annals of Internal Medicine: Clinical Cases, 2022 Pulmonary mucormycosis is a rare entity that requires a high index of clinical suspicion for diagnosis. Untreated mucormycosis results in dissemination with exceedingly high mortality rates.
Chelsea Boyd +2 more
doaj +1 more source